EAH — ECO Animal Health Share Price
Last trade - 00:00- £36.25m
- £29.92m
- £89.42m
- 80
- 56
- 16
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 27.44 | ||
| PEG Ratio (f) | 1.38 | ||
| EPS Growth (f) | 24.92% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.44 | ||
| Price to Tang. Book | 0.85 | ||
| Price to Free Cashflow | 54.27 | ||
| Price to Sales | 0.43 | ||
| EV to EBITDA | 5.09 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.1% | ||
| Return on Equity | 0.8% | ||
| Operating Margin | 3.47% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 72.11 | 105.61 | 82.19 | 85.31 | 89.42 | 85.26 | 88.1 | 5.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -48.98 | +95.9 | -90.9 | +48.68 | +46.56 | -27.5 | +24.92 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ECO Animal Health Group plc is a United Kingdom-based global animal health company. The Company is focused on improving the health and welfare of pigs and poultry. It is engaged in developing and marketing branded veterinary pharmaceuticals globally, in antibiotics and vaccines for pigs and poultry. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. Its segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. It provides products for swine and poultry to treat illness, improving health and performance. Its lead product, Aivlosin, is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. Aivlosin, which is sold in some markets under the tradename Valosin. It also offers a range of products to treat parasites in cattle, sheep and pigs under the brand name Ecomectin.
Directors
- Andrew Jones NEC (61)
- Marc Loomes CEO (60)
- Christopher Wilks FID (57)
- Tracey James NED
- Frank Armstrong NID (64)
- Anthony Rawlinson NID (64)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- May 22nd, 1984
- Public Since
- September 26th, 1995
- No. of Employees
- 222
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 67,759,671
- Address
- 78 Coombe Road, NEW MALDEN, KT3 4QS
- Web
- https://www.ecoanimalhealthgroupplc.com/
- Phone
- +44 2083362900
- Auditors
- Haysmacintyre LLP
Latest News for EAH
Upcoming Events for EAH
Full Year 2025 ECO Animal Health Group PLC Earnings Release
ECO Animal Health Group PLC Annual Shareholders Meeting
Similar to EAH
Alliance Pharma
London Stock Exchange
Animalcare
London Stock Exchange
AstraZeneca
London Stock Exchange
Beximco Pharmaceuticals
London Stock Exchange
BSF Enterprise
London Stock Exchange
FAQ
As of Today at 20:22 UTC, shares in ECO Animal Health are trading at 53.50p. This share price information is delayed by 15 minutes.
Shares in ECO Animal Health last closed at 53.50p and the price had moved by -43.09% over the past 365 days. In terms of relative price strength the ECO Animal Health share price has underperformed the FTSE All Share Index by -45.32% over the past year.
The overall consensus recommendation for ECO Animal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreECO Animal Health does not currently pay a dividend.
ECO Animal Health does not currently pay a dividend.
ECO Animal Health does not currently pay a dividend.
To buy shares in ECO Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 53.50p, shares in ECO Animal Health had a market capitalisation of £36.25m.
Here are the trading details for ECO Animal Health:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: EAH
Based on an overall assessment of its quality, value and momentum ECO Animal Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in ECO Animal Health is 183.00p. That is 242.06% above the last closing price of 53.50p.
Analysts covering ECO Animal Health currently have a consensus Earnings Per Share (EPS) forecast of £0.02 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ECO Animal Health. Over the past six months, its share price has underperformed the FTSE All Share Index by -28.47%.
As of the last closing price of 53.50p, shares in ECO Animal Health were trading -31.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ECO Animal Health PE ratio based on its reported earnings over the past 12 months is 27.44. The shares last closed at 53.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
ECO Animal Health's management team is headed by:
- Andrew Jones - NEC
- Marc Loomes - CEO
- Christopher Wilks - FID
- Tracey James - NED
- Frank Armstrong - NID
- Anthony Rawlinson - NID